NSE/BSE Codes: BSE: 543213, NSE: ROSSARI

Summary of Key Information:

Nature of Event / Disclosure:

Regulatory disclosure under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 regarding update on arbitration proceeding involving material unlisted subsidiary Unitop Chemicals Private Limited.

Involved Parties / Authorities:

  • Rossari Biotech Limited (Company)
  • Sellers (Barkur Dharmaraj Shetty, B.D. Shetty HUF, Saibala Dharmaraj Shetty, Rajeshwari D Shetty, Jeenanath Dharmaraj Shetty and Balakrishna Barkur Shetty)
  • Arbitral Tribunal
  • SEBI (Regulatory authority)
  • BSE Limited and National Stock Exchange of India Limited (Recipients of disclosure)

Date / Timeline of Event:

  • June 02, 2021: Share purchase agreement (SPA) executed between Rossari Biotech and sellers
  • December 13, 2023: Initial disclosure about initiation of Arbitration Proceedings
  • January 21, 2026: Final award passed by Arbitral Tribunal
  • January 29, 2026: Intimation regarding passing of final award
  • June 04, 2026: Company served with petition challenging arbitration award
  • June 04, 2026: Date of this regulatory disclosure

Brief Description of Outcome / Dispute:

The sellers of Unitop Chemicals Private Limited have filed a petition under Section 34 of the Arbitration and Conciliation Act, 1996 challenging the Arbitration Award dated January 21, 2026. This arbitration proceeding was initiated by the sellers under the share purchase agreement entered into by Rossari Biotech Limited on June 02, 2021 with the existing shareholders of Unitop Chemicals Private Limited, which is a material unlisted subsidiary of the Company.

Impact of Outcome:

Financial Impact:

No material disclosures in this section regarding quantitative financial impact, penalties, or specific monetary claims.

Operational / Business / Strategic Impact:

No material disclosures in this section regarding operational disruption, project delays, or specific business consequences.

Other Implications:

The disclosure indicates ongoing legal proceedings that may have regulatory compliance implications under SEBI Listing Regulations. The matter involves a material unlisted subsidiary, suggesting potential significance for corporate governance and investor relations.

Next Steps / Required Actions:

The petition filed under Section 34 of the Arbitration and Conciliation Act, 1996 represents the next legal step in challenging the arbitration award. The company is required to continue making appropriate disclosures under SEBI Listing Regulations as the matter progresses.